Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: Stanard strengthening program.
Total 0 results
Nothing found
Sponsors and Collaborators
Stemina Biomarker Discovery, Inc.
Microsoft Corporation
Stefano Malinverni, MD
Avextra Pharma GmbH
Aider Perpignan : Dr Ahmed RACHI
Duke Clinical and Translational Science Institute (CTSI), part of the NIH Clinical and Translational Science Awards (CTSA)
Luigi Canullo
The Marfan Foundation
Psoriasis Association
Deutsche Klinik Bad Münder
L. Eugene Arnold
Sligo General Hospital
Else Kröner-Fresenius Stiftung, Bad Homburg, Germany
Villarreal CF
CellOxess LLC
Bayfront Health St Petersburg
Wellcome Leap Organization
Natrol
Skidmore College
Dong-A Pharmaceutical Co., Ltd.
View Full List
Medical Conditions
STAT1 Gain-of-Function Disease
Varus Gonarthrosis
Stage IVB Rectal Cancer
Ependymoma, Recurrent Childhood
CT Photon Counting
Liposuction
Osteoarthritis Of Knee
Status Post Methadone-Maintenance Treatment
Zika Virus Symptoms and the Associated Exanthema
Granulomatosis With Polyangiitis
Infertile Women Undergoing IVF or ICSI
Chronic Dacryocystitis
Knee Arthrodesis With Intramedullary Nail
Genome-wide High Throughput Sequencing
Adrenal Masses
Spinocerebellar Ataxias (SCA)
30-day Mortality
Recurrent Squamous Cell Carcinoma of the Hypopharynx
Noninvasive Imaging of Atherosclerosis
Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
View Full List
Drug Interventions
BeneFIX
Pertuzumab IV
Brivanib
Hydroxychloroquine
PEP005 (Ingenol mebutat Gel, 0.05 %)
PZA sensitivity guided ultra-short all Oral Regimen
YY-20394 treatment
Standard of care
Tobramycin
Resin infiltration
Eribulin Mesylate
Paricalcitol
Keytruda
Esomeprazole
36 Weeks Methylprednisolone
Paliperidone ER
0.03% DSC127 topical gel
INCB009471
Temozolomide
Nogapendekin Alfa
View Full List
CROs by country
Contract Research Organizations in Albania
Contract Research Organizations in Armenia
Contract Research Organizations in Bahrain
Contract Research Organizations in Cambodia
Contract Research Organizations in Ecuador
Contract Research Organizations in Guinea
Contract Research Organizations in Ireland
Contract Research Organizations in Kenya
Contract Research Organizations in Liberia
Contract Research Organizations in Macedonia
Contract Research Organizations in Moldova
Contract Research Organizations in Netherlands
Contract Research Organizations in Zimbabwe
CRO list by country
CROs in Gambia
SGS
All CROs in Gambia
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe